640 fundamentals
An in-depth look to CHINA RES.PHARMA.GRP O.N. operating, investing, and financing activities
640 free cash flow for H2 24 is 2.19 B EUR. For 2024, 640 free cash flow was 1.81 B EUR and operating cash flow was 2.18 B EUR.
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: EUR
TTM